Cargando…

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)

Age-related macular degeneration (AMD) is still referred to as the leading cause of severe and irreversible visual loss world-wide. The disease has a profound effect on quality of life of affected individuals and represents a major socioeconomic challenge for societies due to the exponential increas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt-Erfurth, Ursula, Chong, Victor, Loewenstein, Anat, Larsen, Michael, Souied, Eric, Schlingemann, Reinier, Eldem, Bora, Monés, Jordi, Richard, Gisbert, Bandello, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145443/ https://www.ncbi.nlm.nih.gov/pubmed/25136079 http://dx.doi.org/10.1136/bjophthalmol-2014-305702

Ejemplares similares

CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus
por: Wong, Tien Yin, et al.
Publicado: (2020)

Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review
por: Okada, Mali, et al.
Publicado: (2021)

Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022)

Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010)

SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY
por: Wong, David T., et al.
Publicado: (2020)

InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years
por: Cozzupoli, Grazia M., et al.
Publicado: (2022)

Patient and retina specialists’ preferences in neovascular age-related macular degeneration treatment. A discrete choice experiment
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2021)

The management of neovascular age‐related macular degeneration: A systematic literature review of patient‐reported outcomes, patient mental health and caregiver burden
por: Gale, Richard P., et al.
Publicado: (2022)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
por: Matysik-Woźniak, Anna, et al.
Publicado: (2021)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?
por: Haj Najeeb, Bilal, et al.
Publicado: (2022)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration
por: Roberts, Philipp K., et al.
Publicado: (2022)

Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
por: Schütze, Christopher, et al.
Publicado: (2015)

Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
por: Daien, Vincent, et al.
Publicado: (2021)

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome
por: Chung, Wing H, et al.
Publicado: (2016)

Undetectable Macular Neovascularization on OCT Angiography in Age Related Macular Degeneration: Comparison between Different Devices
por: Filali Ansary, Meryem, et al.
Publicado: (2022)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

2-Year Real-World Outcomes with Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: Literature Review and Meta-analysis of Patient-Relevant Outcomes
por: Carrasco, Joao, et al.
Publicado: (2021)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Early detection of age related macular degeneration: current status
por: Schwartz, Roy, et al.
Publicado: (2015)

Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
por: Ricci, Federico, et al.
Publicado: (2020)

Prospective, Longitudinal Pilot Study: Daily Self-Imaging with Patient-Operated Home OCT in Neovascular Age-Related Macular Degeneration
por: Keenan, Tiarnan D.L., et al.
Publicado: (2021)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
por: Razavi, Sam, et al.
Publicado: (2021)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
por: Muth, Daniel Rudolf, et al.
Publicado: (2022)

Profiling neovascular age‐related macular degeneration choroidal neovascularization lesion response to anti‐vascular endothelial growth factor therapy using SSOCTA
por: Told, Reinhard, et al.
Publicado: (2020)

Short‐time effect of intravitreal injections on retinal vascular oxygenation and vessel diameter in patients with diabetic macular oedema or neovascular age‐related macular degeneration
por: Mitsch, Christoph, et al.
Publicado: (2019)

Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
por: Bogunović, Hrvoje, et al.
Publicado: (2022)

Correlation of vascular and fluid‐related parameters in neovascular age‐related macular degeneration using deep learning
por: Schranz, Markus, et al.
Publicado: (2022)

The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2020)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Genetic association study of mitochondrial polymorphisms in neovascular age-related macular degeneration
por: Tilleul, Julien, et al.
Publicado: (2013)

Sub-retinal pigment epithelium tubules in non-neovascular age-related macular degeneration
por: Fragiotta, Serena, et al.
Publicado: (2022)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission
por: Coscas, Florence, et al.
Publicado: (2018)

Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials
por: Kodjikian, Laurent, et al.
Publicado: (2014)

The Injection Practice Patterns of Retina Specialists in Managing Exudative Age-Related Macular Degeneration: A Retrospective Study
por: Karimaghaei, Cina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ms5n3lbf8ca8ph7eggkigbqa2p